Browse by Number or Letter
[18F]-Labeled Substance P Antagonist Receptor Quantifier is a special radioactive tracer used in PET scans. It attaches to certain receptors found on nerve cells and some pancreatic cancer cells, helping doctors see where cancer may have spread. This tracer is still being studied and is not yet a standard test for cancer detection or monitoring.
[18F]SPA-RQ is a special radioactive substance used in PET scans to help doctors see certain brain areas and to study where cancer cells might have spread, especially in pancreatic cancer. It attaches to specific cell receptors, making those areas visible during imaging. This tracer is still being researched and is not yet a routine part of cancer care.
1-(2’-Deoxy-2’-Fluoro-β-D-Arabinofuranosyl) Uracil, also called FAU, is a substance being studied as a possible treatment for advanced solid tumors and lymphomas. It works by blocking cancer cells from growing and may cause them to die. FAU is still experimental and not yet approved for routine cancer treatment. It may also appear under related names such as FAU.
1-Methyl-D-Tryptophan, also called D-1MT, is a substance being studied to help treat melanoma and other cancers. It works by blocking the breakdown of tryptophan, an amino acid that immune cells called T cells need to attack cancer cells. It may be given after chemotherapy to help the immune system kill more tumor cells. It is not yet a standard treatment but is being researched in clinical trials.
1-Pentadecene is a natural chemical found in the defensive secretions of certain beetles, such as Ulomoides dermestoides. It is a volatile organic compound, meaning it easily evaporates into the air. While studied for its role in insect behavior, 1-pentadecene is not proven to have any effect on cancer treatment or prevention.
1-Tridecene is a natural chemical produced by certain beetles, acting as a scent or defensive compound. It belongs to a group called alkenes and is part of some insect secretions. While it may appear in scientific or environmental health discussions, 1-Tridecene is not known to cause or treat cancer and is not used in cancer care.
10-Propargyl-10-Deazaaminopterin is an experimental drug being studied for cancer treatment. It belongs to a group called folate analogs, which affect how cells grow and divide. This drug is not yet approved for routine use but may be available through clinical trials. Patients might hear about it when exploring new treatment options or research studies.
111In-ibritumomab tiuxetan is a special medicine that combines an antibody with a small amount of radioactive material. It attaches to B cells by targeting a protein called CD20. Doctors use it mainly to help find certain B-cell non-Hodgkin lymphomas by showing where it collects in the body with a scanning machine.
111In-Zevalin is a special medicine that combines a lab-made antibody with a small amount of radioactive material. It attaches to a protein called CD20 on B cells, a type of immune cell. Doctors use it mainly to help find certain B-cell non-Hodgkin lymphomas by showing where the medicine collects in the body with a scanning machine. It is a tool to help locate cancer cells, not a treatment.
11C-Acetate is a radioactive substance used in PET scans to help find cancer in the body. Cancer cells absorb more of it than normal cells, making tumors easier to see. It is still being studied and is not yet a routine test but may be used in specialized centers or research to better understand certain cancers.
11C-Choline, also called carbon C 11-choline, is a small amount of radioactive choline used in PET scans to help find certain cancers. Cancer cells absorb more 11C-choline than normal cells, so the scan highlights areas where cancer might be present. This imaging test helps doctors locate tumors, check for spread, or monitor treatment, but it is not used for all cancers or in every hospital.
An 11C-Choline PET-CT scan is a medical imaging test that uses a small amount of radioactive choline injected into a vein. A special scanner then creates detailed pictures showing where the choline collects in the body. Because cancer cells absorb more choline than normal cells, this scan helps doctors find cancer and see where it might have spread.
12-O-Tetradecanoylphorbol-13-acetate, also called tetradecanoylphorbol acetate, is a chemical being studied for its effects on cancer cells. It may help cause cancer cells to die and is being researched mainly for blood cancers like leukemias and lymphomas. It is not yet an approved treatment but is part of ongoing cancer research.
123I-MIBG is a special drug containing a small amount of radioactive iodine (I-123) used in imaging tests to help find certain tumors, such as pheochromocytomas and neuroblastomas. It helps doctors see where cancer cells may be in the body by highlighting them during scans. It is also called AdreView or iobenguane I 123.
126–F is a liquid mixture once promoted as a cancer treatment under names like Cancell, Cantron, and Protocel. None of its ingredients have been proven to treat cancer. Since 1989, it has been illegal in the U.S. to make, sell, or give 126–F for any disease because it lacks scientific support and may delay effective care.
13-Cis retinoic acid, also known as isotretinoin, is a medicine related to vitamin A. It is commonly used to treat severe acne and some skin conditions. In cancer care, it helps treat certain cancers like neuroblastoma by affecting how cancer cells grow and behave. Doctors use it carefully as part of cancer treatment or prevention plans.
131I-MIBG is a medicine that uses a radioactive form of iodine to treat certain rare tumors called malignant pheochromocytoma or paraganglioma in adults and children aged 12 and older. It works by targeting tumor cells and delivering radiation to help kill them. It is also being studied for use in other cancers.
The 1572 Form, also called Form FDA 1572 or Statement of Investigator, is a document that a doctor or researcher must file before starting a clinical trial. By signing it, the investigator promises to follow FDA rules and confirms they have the experience and resources to conduct the trial safely and ethically. This helps protect patients and ensures the study meets important standards.
17-AAG, also called tanespimycin, is an experimental drug studied for cancer treatment. It is made from an antibiotic called geldanamycin and works by blocking a protein inside cells that helps cancer cells survive. By interfering with this protein, 17-AAG may cause cancer cells to die or stop growing. It is not yet a standard treatment and is mainly available through clinical trials.
17-Dimethylaminoethylamino-17-Demethoxygeldanamycin, or 17-DMAG, is an experimental drug being studied for cancer treatment. It belongs to a group of drugs called geldanamycin analogs that target proteins helping cancer cells survive. While promising, 17-DMAG is not yet approved for routine use and is mainly seen in clinical trials or research settings. This entry helps connect the word with diagnoses, testing, treatments, supportive care, research notes, protocols, media, books, people, organizations, and safety concerns.
17-N-Allylamino-17-Demethoxygeldanamycin, also called 17-AAG or tanespimycin, is an experimental drug studied for cancer treatment. It is made from an antibiotic called geldanamycin and works by blocking a protein inside cells that helps cancer cells survive. This drug is not yet a standard treatment and is mainly available through clinical trials.
17P deletion is a genetic change where part or all of the short arm (p arm) of chromosome 17 is missing. This loss includes the TP53 gene, which helps control cell growth and prevent cancer. It is linked to some blood cancers like leukemia, multiple myeloma, and myelodysplastic syndrome. Testing for 17P deletion helps doctors diagnose cancer, plan treatment, and understand prognosis.
18F-16 Alpha-Fluoroestradiol (also called 18F-FES) is a special radioactive substance used in PET scans to find breast cancer cells that have estrogen receptors. It helps doctors see where hormone-sensitive cancer cells are in the body, which can guide treatment decisions, especially about hormone therapy. It may also appear under related names such as 18F-FES, Fluorine F 18-16 Alpha-Fluoroestradiol.
18F-Choline is a radioactive tracer used in PET scans to help find certain cancers. Cancer cells absorb more 18F-Choline than normal cells, making it easier for doctors to see where cancer might be in the body. It is also called 18F-fluoromethylcholine or 18F-FMCH and is still being studied for wider use.
18F-EF5, also called fluorine F 18-EF5, is a radioactive tracer used in PET scans to highlight cancer cells with low oxygen levels (hypoxia). This special imaging helps doctors learn more about how a tumor might respond to treatment. It is still being studied and is not a routine test for all cancer patients.
18F-FES is a special radioactive substance used in PET scans to find breast cancer cells that have estrogen receptors. It helps doctors see where hormone-sensitive cancer cells are in the body, which can guide treatment decisions, especially about hormone therapy. This imaging test is still being studied and is not yet a routine part of breast cancer care.
18F-FLT is a radioactive tracer used in special imaging tests to help find and study cancer. Injected into the bloodstream, it collects in cells that are actively dividing, including cancer cells. During a PET scan, the radiation it emits helps create detailed pictures of tumors, supporting doctors in diagnosis and monitoring. It is still being studied and not yet a routine test.
18F-Fludeoxyglucose (FDG) is a radioactive sugar used in PET scans to help find cancer and other abnormal cells. Cancer cells often absorb more FDG than normal cells, making them visible on the scan. This helps doctors locate tumors, understand how active they are, and sometimes check how well treatment is working.
18F-Fluoromethylcholine is a radioactive tracer used in PET scans to help find certain cancers. Cancer cells absorb more of this substance than normal cells, making it easier for doctors to see where cancer might be in the body. It is also called 18F-choline or 18F-FMCH and is still being studied for wider use.
18F-Fluoromisonidazole (also called 18F-MISO or FMISO) is a radioactive tracer used in special PET scans to find cancer cells with low oxygen levels. These low-oxygen areas, called hypoxia, can make tumors harder to treat. This imaging helps doctors see where hypoxia exists in tumors, which may guide treatment choices and provide information about how the cancer might behave.
18F-Fluorothymidine (18F-FLT) is a radioactive tracer used in special imaging tests to help find and study cancer. Injected into the bloodstream, it collects in cells that are actively dividing, including cancer cells. During a PET scan, the radiation it emits helps create detailed pictures of tumors, supporting doctors in diagnosis and monitoring. It is still being studied and not yet a routine test.
18F-FMCH, also called 18F-choline or 18F-fluoromethylcholine, is a radioactive substance used in PET scans to help find certain cancers. Cancer cells absorb more of this tracer than normal cells, making it easier for doctors to see where cancer might be in the body. It is still being studied and is not yet a standard test everywhere.
18F-MISO (also called 18F-Fluoromisonidazole or FMISO) is a radioactive tracer used in special PET scans to find cancer cells with low oxygen levels. It helps doctors see areas in tumors where oxygen is scarce, which can affect how the cancer responds to treatment. This imaging is mainly studied in head and neck cancers and may help guide treatment decisions and predict cancer behavior.
18F-NaF PET is a special bone scan that helps doctors check if cancer has spread to the bones. It uses a small injection of a radioactive substance called 18F-sodium fluoride, which collects more in areas affected by cancer. The scan creates detailed images showing these areas, helping guide diagnosis and treatment decisions.
18F-Sodium Fluoride Positron Emission Tomography (18F-NaF PET) is a special bone scan that helps doctors check if cancer has spread to the bones. It uses a small injection of a safe radioactive substance that collects more in affected bones. A PET scanner then creates detailed images showing these areas to guide diagnosis and treatment.
1H-Nuclear Magnetic Resonance Spectroscopic Imaging (MRSI) is a noninvasive scan that measures chemical activity inside cells. Often done with MRI scans, it helps doctors see not just the size and shape of tumors but also how tumor cells are working. This combined information can support diagnosis, treatment planning, and monitoring in cancer care.